Manufacturing / Pharmaceutical Preparations
Annovis Bio, Inc.
ANVS
$1.16
$0.00 (-0.16%)
Price as of Oct 9, 2026 16:39 UTC
75 M
Market Cap (Micro Cap)
Nov 10
Next Earnings
Technical Signals
as of Oct 7
Bearish
0 of 7
Trend
- Above 20-day average $1.27
- Above 50-day average $1.45
- Above 200-day average $2.07 · -41.6%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 173d ago
Volume
- Below-average volume 0.4x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for ANVS options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
19 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| May 20, 2026 | Hoffman Michael B | Buy | 18,849 | $33,928 | -35.0% | |
| May 20, 2026 | Hoffman Michael B | Buy | 54,933 | $104,367 | -38.4% | |
| May 20, 2026 | Hoffman Michael B | Other | 54,933 | $104,367 | -38.4% | |
| May 20, 2026 | Hoffman Michael B | Buy | 2,562 | $4,484 | -33.1% | |
| May 20, 2026 | Hoffman Michael B | Other | 18,849 | $33,928 | -35.0% | |
| May 20, 2026 | Hoffman Michael B | Other | 2,562 | $4,484 | -33.1% | |
| Apr 02, 2026 | Hoffman Michael B | Buy | 713,800 | $1,498,980 | -44.3% | |
| Apr 02, 2026 | Hoffman Michael B | Other | 713,800 | $1,498,980 | -44.3% | |
| Dec 08, 2025 | Hoffman Michael B | Other | 30,000 | $130,194 | -73.0% | |
| Dec 08, 2025 | Hoffman Michael B | Buy | 15,000 | $63,600 | -72.4% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 10, 2026 | Q2 2026 | -$0.46 | |||
| Mar 31, 2026 | Q1 2026 | -$0.40 | -$0.63 | -56.4% | Miss |
| Dec 31, 2025 | Q4 2025 | -$0.35 | -$0.39 | -11.4% | Miss |
| Sep 30, 2025 | Q3 2025 | -$0.31 | -$0.37 | -18.9% | Miss |
| Jun 30, 2025 | Q2 2025 | -$0.41 | -$0.32 | +22.1% | Beat |
| Mar 31, 2025 | Q1 2025 | -$0.36 | -$0.32 | +12.0% | Beat |
Track ANVS with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for ANVS and your entire portfolio.